第一例抗血友病因子(AHF)经分离浓缩后用于治疗血友病患者的凝血功能障碍。
The first antihemophilic factor (AHF) concentrate to treat coagulation disorders in hemophilia patients is developed through fractionation.
这种必须的凝血蛋白，即精制灭菌冻干人抗血友病因子由美国仔细筛选的供体血浆中精制而来，并经处理以降低输血传播疾病的风险。
The much needed clotting protein from human plasma from carefully screened US donors is purified - this is Humate-P. Measures are taken to lessen the risk of transfusion-transmitted diseases.
这种必须的凝血蛋白，即精制灭菌冻干人抗血友病因子由美国仔细筛选的供体血浆中精制而来，并经处理以降低输血传播疾病的风险。
The much needed clotting protein from human plasma from carefully screened US donors is purified - this is Humate-P. Measures are taken to lessen the risk of transfusion-transmitted diseases.
应用推荐